US EditionImplications of the Fragility of Opioid Agonist Treatment Continuity on Hepatitis C Re-Exposure Concerns Among People in Prison: A Qualitative Study – hepCoalition
Summary by hepCoalition
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Implications of the Fragility of Opioid Agonist Treatment Continuity on Hepatitis C Re-Exposure Concerns Among People in Prison: A Qualitative Study – hepCoalition
A study explored people's experiences and utilisation of opioid agonist treatment as a risk reduction strategy while incarcerated. Prevention / Prisons, Harm reduction, People who use drugs
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
